FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313312491> ?p ?o ?g. }

• W4313312491 endingPage "506" @default.
• W4313312491 startingPage "492" @default.
• W4313312491 abstract "Overactive bladder (OAB) symptoms of frequency, urgency and urge incontinence are frequently associated with known neurological diseases like multiple sclerosis (MS), spinal cord injury (SCI), Parkinson's disease (PD), stroke.The aim of our study was to review the efficacy of pharmacological and non-pharmacological treatments for neurogenic overactive bladder.We searched two electronic databases (PubMed and EMBASE) for randomized controlled trials focusing on pharmacological and non-pharmacological medical treatments for overactive bladder symptoms associated with neurological diseases published up to 30 April 2022.A total of 157 articles were retrieved; 94 were selected by title and abstract screening; after removal of 17 duplicates, 77 records were evaluated by full-text examination. Sixty-two studies were finally selected. The articles selected for review focused on the following interventions: anticholinergics (n = 9), mirabegron (n = 5), comparison of different drugs (n = 3), cannabinoids (n = 2), intravesical instillations (n = 3), botulinum toxin (n = 16), transcutaneous tibial nerve stimulation (TTNS) (n = 6), acupuncture (n = 2), transcutaneous electrical nerve stimulation TENS (n = 4), pelvic floor muscle training (PFMT) (n = 10), others (n = 2). Anticholinergics were more effective than placebo in decreasing the number of daily voids in patients with PD (mean difference [MD]- 1.16, 95 % CI - 1.80 to - 0.52, 2 trials, 86 patients, p < 0.004), but no significant difference from baseline was found for incontinence episodes and nocturia. Mirabegron was more effective than placebo in increasing the cystometric capacity in patients with MS (mean difference [MD] 89.89 mL, 95 % CI 29.76 to 150.01, 2 trials, 98 patients, p < 0.003) but no significant difference was observed for symptom scores and bladder diary parameters. TTNS was more effective than its sham-control in decreasing the number of nocturia episodes (MD -1.40, 95 % CI -2.39 to -0.42, 2 trials, 53 patients, p < 0.005) but no significant changes of OAB symptom scores were reported. PFMT was more effective than conservative advice in decreasing the ICIQ symptom score (MD, -1.12, 95 % CI -2.13 to -0.11, 2 trials, 91 patients, p = 0.03), although the number of incontinence episodes was not significantly different between groups.The results of the meta-analysis demonstrate a moderate efficacy of all considered treatments without proving the superiority of one therapy over the others. Combination treatment using different pharmacological and non-pharmacological therapies could achieve the best clinical efficacy due to the favorable combination of the different mechanisms of action. This could be associated with fewer side effects due to drug dosage reduction. These data are only provisional and should be considered with caution, due to the few studies included in metaanalysis and to the small number of patients." @default.
• W4313312491 created "2023-01-06" @default.
• W4313312491 creator A5001837916 @default.
• W4313312491 creator A5002741156 @default.
• W4313312491 creator A5010686495 @default.
• W4313312491 creator A5012976194 @default.
• W4313312491 creator A5029010585 @default.
• W4313312491 creator A5034143660 @default.
• W4313312491 creator A5039985810 @default.
• W4313312491 creator A5046174197 @default.
• W4313312491 creator A5056812291 @default.
• W4313312491 creator A5060755181 @default.
• W4313312491 creator A5069884302 @default.
• W4313312491 creator A5070850743 @default.
• W4313312491 creator A5078242740 @default.
• W4313312491 creator A5083698275 @default.
• W4313312491 date "2022-12-28" @default.
• W4313312491 modified "2023-10-12" @default.
• W4313312491 title "Efficacy of overactive neurogenic bladder treatment: A systematic review of randomized controlled trials" @default.
• W4313312491 cites W104992362 @default.
• W4313312491 cites W1129255255 @default.
• W4313312491 cites W147192028 @default.
• W4313312491 cites W1564128050 @default.
• W4313312491 cites W1578011271 @default.
• W4313312491 cites W1600148322 @default.
• W4313312491 cites W1759982868 @default.
• W4313312491 cites W1852390498 @default.
• W4313312491 cites W1920922907 @default.
• W4313312491 cites W1968701973 @default.
• W4313312491 cites W1976848876 @default.
• W4313312491 cites W1985267005 @default.
• W4313312491 cites W1985454124 @default.
• W4313312491 cites W1997434385 @default.
• W4313312491 cites W2014044503 @default.
• W4313312491 cites W2022120101 @default.
• W4313312491 cites W2027539812 @default.
• W4313312491 cites W2034740672 @default.
• W4313312491 cites W2037536588 @default.
• W4313312491 cites W2041926096 @default.
• W4313312491 cites W2042323300 @default.
• W4313312491 cites W2044720944 @default.
• W4313312491 cites W2050398156 @default.
• W4313312491 cites W2057187748 @default.
• W4313312491 cites W2059772179 @default.
• W4313312491 cites W2059903851 @default.
• W4313312491 cites W2063646746 @default.
• W4313312491 cites W206367589 @default.
• W4313312491 cites W2063677232 @default.
• W4313312491 cites W2080237392 @default.
• W4313312491 cites W2081071477 @default.
• W4313312491 cites W2081180442 @default.
• W4313312491 cites W2090102990 @default.
• W4313312491 cites W2102524054 @default.
• W4313312491 cites W2104265850 @default.
• W4313312491 cites W2109273797 @default.
• W4313312491 cites W2112303081 @default.
• W4313312491 cites W2114935139 @default.
• W4313312491 cites W2126139018 @default.
• W4313312491 cites W2147101940 @default.
• W4313312491 cites W2152343213 @default.
• W4313312491 cites W2153171524 @default.
• W4313312491 cites W2233327055 @default.
• W4313312491 cites W2236155142 @default.
• W4313312491 cites W2284801676 @default.
• W4313312491 cites W2314650606 @default.
• W4313312491 cites W2315302733 @default.
• W4313312491 cites W2325008077 @default.
• W4313312491 cites W2332927536 @default.
• W4313312491 cites W2610370749 @default.
• W4313312491 cites W2737315404 @default.
• W4313312491 cites W2767578860 @default.
• W4313312491 cites W2889116823 @default.
• W4313312491 cites W2908290262 @default.
• W4313312491 cites W2932062038 @default.
• W4313312491 cites W2949624894 @default.
• W4313312491 cites W2970684805 @default.
• W4313312491 cites W2979769777 @default.
• W4313312491 cites W2982005870 @default.
• W4313312491 cites W3004851042 @default.
• W4313312491 cites W3006295293 @default.
• W4313312491 cites W3041862261 @default.
• W4313312491 cites W3115447090 @default.
• W4313312491 cites W3120934386 @default.
• W4313312491 cites W3133612406 @default.
• W4313312491 cites W3164784316 @default.
• W4313312491 cites W3165483902 @default.
• W4313312491 cites W3201298114 @default.
• W4313312491 cites W3207444053 @default.
• W4313312491 cites W4210417186 @default.
• W4313312491 cites W4210539390 @default.
• W4313312491 cites W4223651460 @default.
• W4313312491 cites W4225864684 @default.
• W4313312491 cites W4284899311 @default.
• W4313312491 cites W4294215472 @default.
• W4313312491 doi "https://doi.org/10.4081/aiua.2022.4.492" @default.
• W4313312491 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36576454" @default.
• W4313312491 hasPublicationYear "2022" @default.
• W4313312491 type Work @default.

• next